انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Key PBC Studies From AASLD 2024
Manage episode 459841321 series 2884624
In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including:
- ELATIVE, a phase III trial of elafibranor for PBC
- RESPONSE, a phase III trial of seladelpar for PBC
- ASSURE, another phase III trial of seladelpar for PBC
Presenter:
Sonal Kumar, MD, MPH
Director, Clinical Gastroenterology and Hepatology
Assistant Professor of Medicine
Weill Cornell Medical College
New York, New York
Link to full program:
https://bit.ly/41tvSDu
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
431 حلقات
Manage episode 459841321 series 2884624
In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including:
- ELATIVE, a phase III trial of elafibranor for PBC
- RESPONSE, a phase III trial of seladelpar for PBC
- ASSURE, another phase III trial of seladelpar for PBC
Presenter:
Sonal Kumar, MD, MPH
Director, Clinical Gastroenterology and Hepatology
Assistant Professor of Medicine
Weill Cornell Medical College
New York, New York
Link to full program:
https://bit.ly/41tvSDu
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
431 حلقات
كل الحلقات
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.